Debt-to-equity of Nascent Biotech Inc. from 30 Sep 2015 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nascent Biotech Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 30 Jun 2024.
  • Nascent Biotech Inc. Debt-to-equity for the quarter ending 30 Jun 2024 was -430%, a 200% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Nascent Biotech Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 -430% -287% -200% 30 Jun 2024
Q1 2024 -275% -133% -94% 31 Mar 2024
Q4 2023 -186% -42% -29% 31 Dec 2023
Q3 2023 -152% +7.4% +4.7% 30 Sep 2023
Q2 2023 -143% -11% -8.6% 30 Jun 2023
Q1 2023 -142% -0.43% -0.3% 31 Mar 2023
Q4 2022 -144% +23% +14% 31 Dec 2022
Q3 2022 -160% -26% -20% 30 Sep 2022
Q2 2022 -132% +4% +2.9% 30 Jun 2022
Q1 2022 -141% -18% -14% 31 Mar 2022
Q4 2021 -167% -65% -63% 31 Dec 2021
Q3 2021 -134% -32% -31% 30 Sep 2021
Q2 2021 -136% -36% -36% 30 Jun 2021
Q1 2021 -124% -23% -23% 31 Mar 2021
Q4 2020 -103% +2.3% +2.2% 31 Dec 2020
Q3 2020 -102% +8.5% +7.7% 30 Sep 2020
Q2 2020 -100% +17% +15% 30 Jun 2020
Q1 2020 -100% +23% +19% 31 Mar 2020
Q4 2019 -105% +24% +19% 31 Dec 2019
Q3 2019 -110% +655% +86% 30 Sep 2019
Q2 2019 -118% -180% -290% 30 Jun 2019
Q1 2019 -123% -152% -525% 31 Mar 2019
Q4 2018 -129% -150% -728% 31 Dec 2018
Q3 2018 -765% -786% -3669% 30 Sep 2018
Q2 2018 62% +40% +187% 30 Jun 2018
Q1 2018 29% -88% -75% 31 Mar 2018
Q4 2017 21% +1133% 31 Dec 2017
Q3 2017 21% +347% 30 Sep 2017
Q2 2017 22% +224% 30 Jun 2017
Q1 2017 117% +289% 31 Mar 2017
Q4 2016 -1112% -954% -605% 31 Dec 2016
Q3 2016 -326% -182% -127% 30 Sep 2016
Q2 2016 -203% 30 Jun 2016
Q1 2016 -173% 31 Mar 2016
Q4 2015 -158% 31 Dec 2015
Q3 2015 -144% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.